Atlas Trials

Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China

Clinical trial NCT03792529 · UNKNOWN

Trial details

NCT number
NCT03792529
Sponsor
Peking University Cancer Hospital & Institute
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2017-07-20
Primary completion
2019-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.